- Title:
Issue of equity/PDMR Dealing - Time:
07:00:04 - Date:
30 Jul 2021 - Category:
Capital structure - ID:
9852G
MyHealthChecked Plc
("MyHealthChecked" or the "Company")
Issue of equity/PDMR Dealing
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, reports it has today allotted 3,000,000 ordinary shares of 0.1 pence each ("New Ordinary Shares").
2,500,000 of these shares were allotted following the exercise of options by a former director of the Company.
The consideration for the exercise of the New Ordinary Shares is £20,000 in cash.
A further 500,000 shares were allotted to Penny McCormick, Chief Executive, in lieu of her 2020 bonus of £17,500 at an issue price of 3.5 pence, being the mid-market price at close of business on 28 July 2021.
The New Ordinary Shares were allotted on 29 July 2021. Application will be made for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to be on or about 4 August 2021. These shares will rank pari passu with the ordinary shares of the Company in issue.
Total voting rights
For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following Admission will consist of 756,088,967 ordinary shares of 0.1 pence each ("Ordinary Shares") with voting rights attached (one vote per Ordinary Share). There are no Ordinary Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.
In addition, on 29 July 2021 the Company issued the following options over new Ordinary Shares as set out below, at an exercise price of 3.5 pence per Ordinary Share, being the mid-market price at close of business on 28 July 2021.
| Name of Director / PDMR |
Number of Director Options Granted |
Share Option Scheme |
Exercise Price |
Vesting Conditions |
End of Exercise Period |
| Penny McCormick |
4,857,000 |
Enterprise Management Incentive ("EMI") Scheme |
£0.035 |
One-third vest in 1, 2 and 3 year's time |
28/7/2031 |
| Penny McCormick |
5,143,000 |
Unapproved Scheme |
£0.035 |
One-third vest in 1, 2 and 3 year's time |
28/7/2031 |
| Gareth Davies |
4,000,000 |
EMI Scheme |
£0.035 |
One-third vest in 1, 2 and 3 year's time |
28/7/2031 |
| Lyn Rees |
2,000,000 |
Unapproved Scheme |
£0.035 |
One-third vest in 1, 2 and 3 year's time |
28/7/2031 |
| Adam Reynolds |
1,000,000 |
Unapproved Scheme |
£0.035 |
One-third vest in 1, 2 and 3 year's time |
28/7/2031 |
In addition, 3,000,000 options in aggregate have been granted to other staff members under the EMI Scheme, and a further 2,000,000 under the Unapproved Scheme to consultants to the Company. All these options have the same exercise price.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
| 1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
| a)
|
Name
|
Penny McCormick |
|||
| 2
|
Reason for the notification
|
||||
| a)
|
Position/status
|
Chief Executive Officer |
|||
| b)
|
Initial notification /Amendment
|
Initial Notification |
|||
| 3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
| a)
|
Name
|
MYHEALTHCHECKED plc |
|||
| b)
|
LEI
|
213800RBHY6LZDG13168
|
|||
| CO4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
| a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares
|
|||
| |
|
||||
| Identification code |
ISIN: GB00BYZ2R301 |
||||
| |
|
||||
| b)
|
Nature of the transaction
|
Issue of share options
Issue of shares |
|||
| c)
|
Price(s) and volume(s) |
|
(i) Options issue: |
|
|
| |
|
Price(s) |
Volume(s) |
|
|
| |
|
£0.035 |
10,000,000 |
|
|
| |
|
(ii) Issue of shares Price(s) £0.035
|
Volumes(s) 500,000
|
|
|
| d)
|
Aggregated information |
|
|||
| |
|
||||
| - Aggregated volume |
As above |
||||
| |
|
||||
| - Price |
|
||||
| |
|
||||
| e)
|
Date of the transaction
|
29 July 2021 |
|||
| f)
|
Place of the transaction
|
Outside a trading venue |
|||
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
| 1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
| a)
|
Name
|
Gareth Davies |
|||
| 2
|
Reason for the notification
|
||||
| a)
|
Position/status
|
Chief Financial Officer |
|||
| b)
|
Initial notification/Amendment
|
Initial Notification |
|||
| 3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
| a)
|
Name
|
MYHEALTHCHECKED plc |
|||
| b)
|
LEI
|
213800RBHY6LZDG13168
|
|||
| 4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
| a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares
|
|||
| |
|
||||
| Identification code |
ISIN: GB00BYZ2R301 |
||||
| |
|
||||
| b)
|
Nature of the transaction
|
Issue of share options |
|||
| c)
|
Price(s) and volume(s) |
|
|
|
|
| |
|
Price(s) |
Volume(s) |
|
|
| |
|
£0.035 |
4,000,000 |
|
|
| |
|
|
|
|
|
| d)
|
Aggregated information |
|
|||
| |
|
||||
| - Aggregated volume |
As above |
||||
| |
|
||||
| - Price |
|
||||
| |
|
||||
| e)
|
Date of the transaction
|
29 July 2021 |
|||
| f)
|
Place of the transaction
|
Outside a trading venue |
|||
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
| 1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
| a)
|
Name
|
Lyn Rees |
|||
| 2
|
Reason for the notification
|
||||
| a)
|
Position/status
|
Non-Executive Director |
|||
| b)
|
Initial notification /Amendment
|
Initial Notification |
|||
| 3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
| a)
|
Name
|
MYHEALTHCHECKED plc |
|||
| b)
|
LEI
|
213800RBHY6LZDG13168
|
|||
| 4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
| a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares
|
|||
| |
|
||||
| Identification code |
ISIN: GB00BYZ2R301 |
||||
| |
|
||||
| b)
|
Nature of the transaction
|
Issue of share options |
|||
| c)
|
Price(s) and volume(s) |
|
|
|
|
| |
|
Price(s) |
Volume(s) |
|
|
| |
|
£0.035 |
2,000,000 |
|
|
| |
|
|
|
|
|
| d)
|
Aggregated information |
|
|||
| |
|
||||
| - Aggregated volume |
As above |
||||
| |
|
||||
| - Price |
|
||||
| |
|
||||
| e)
|
Date of the transaction
|
29 July 2021 |
|||
| f)
|
Place of the transaction
|
Outside a trading venue |
|||
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
| 1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
| a)
|
Name
|
Adam Reynolds |
|||
| 2
|
Reason for the notification
|
||||
| a)
|
Position/status
|
Non-Executive Chairman |
|||
| b)
|
Initial notification /Amendment
|
Initial Notification |
|||
| 3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
| a)
|
Name
|
MYHEALTHCHECKED plc |
|||
| b)
|
LEI
|
213800RBHY6LZDG13168
|
|||
| 4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
| a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares
|
|||
| |
|
||||
| Identification code |
ISIN: GB00BYZ2R301 |
||||
| |
|
||||
| b)
|
Nature of the transaction
|
Issue of share options |
|||
| c)
|
Price(s) and volume(s) |
|
|
|
|
| |
|
Price(s) |
Volume(s) |
|
|
| |
|
£0.035 |
1,000,000 |
|
|
| |
|
|
|
|
|
| d)
|
Aggregated information |
|
|||
| |
|
||||
| - Aggregated volume |
As above |
||||
| |
|
||||
| - Price |
|
||||
| |
|
||||
| e)
|
Date of the transaction
|
29 July 2021 |
|||
| f)
|
Place of the transaction
|
Outside a trading venue |
|||
For further information please visit http://www.myhealthcheckedplc.com/ or contact:
| MyHealthChecked plc |
|
| Penny McCormick, Chief Executive Officer |
via Walbrook PR |
| Gareth Davies, Chief Financial Officer |
|
| |
|
| SPARK Advisory Partners Limited (NOMAD) |
Tel: +44 (0)20 3368 3550 |
| Neil Baldwin |
|
| |
|
| Oberon Investments (Broker) |
Tel: +44 (0)203 179 5344 |
| Mike Seabrook |
|
| |
|
| Walbrook PR Ltd (Media & Investor Relations) |
Tel: +44 (0)20 7933 8780 or [email protected] |
| Paul McManus |
Mob: +44(0)7980 541 893 |
The persons responsible for arranging the release of this Announcement on behalf of the Company are Penny McCormick, CEO, and Gareth Davies, Chief Financial and Operations Officer respectively.
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Issue of equity/PDMR Dealing07:00:0430 Jul 2021Capital structure9852G